Moreover, p53 mutations are frequently detected in patients with high-grade serous and clear cell carcinomas, which are associated with an aggressive clinical course [12], suggesting the possibility that p53 mutations mediate features of the invasive and metastatic behavior of EC cells. The gene discussed is TP53; the disease is clear cell adenocarcinoma.